Veronika Gebel

High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia

A. Schambach, W. Wels, U. Modlich, 2020, Frontiers in Immunology.

Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment

H. Schild, D. Dudziak, Lukas Heger, 2021, Frontiers in Immunology.

Non-Viral Sleeping Beauty Transposon Engineered CD19-CAR-NK Cells Show a Safe Genomic Integration Profile and High Antileukemic Efficiency

W. Wels, Z. Ivics, M. Hudecek, 2021, Blood.